Immediate percutaneous coronary intervention (PCI) is the treatment of choice for acute ST-segment elevation myocardial infarction. In this study, PCI that was "facilitated" by pretreatment with reteplase plus abciximab or abciximab alone did not improve clinical outcomes and increased bleeding, calling into question the use of facilitated PCI for the treatment of acute myocardial infarction.
More...